VF
CADL icon

Virtu Financial’s Candel Therapeutics CADL Stock Holding History

Virtu Financial’s Portfolio CADL Stock Details CADL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$299K Buy
+28,997
New +$219K 0.01% 738
2026
Q1 		– Sell
-26,832
Closed -$152K – 1688
2025
Q4 		$152K Buy
+26,832
New +$144K 0.01% 1107
2024
Q3 		– Sell
-22,639
Closed -$140K – 1418
2024
Q2 		$140K Buy
+22,639
New +$170K 0.01% 783

Other funds holding CADL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $2.67B AUM 169.09% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $697M AUM 628.57% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Virtu Financial's CADL Position: Q2 2026 in Review

Virtu Financial opened a new position in Candel Therapeutics (CADL) in Q2 2026: 28,997 shares worth $299K. The stake represents 0.01% of the portfolio and ranks #738 among its holdings. This is a return to the name: Virtu Financial previously reported a position in CADL as recently as Q4 2025.

Virtu Financial first reported a position in CADL in Q2 2024 and has held it in 3 quarters since. 138 funds tracked by Wall St. Rank hold CADL as of Q2 2026.

  • Virtu Financial held 28,997 shares of Candel Therapeutics worth $299K as of Q2 2026.
  • Candel Therapeutics was a new Virtu Financial position in Q2 2026.
  • Candel Therapeutics made up 0.01% of Virtu Financial's portfolio in Q2 2026, its #738 holding.
  • Virtu Financial first reported a position in Candel Therapeutics in Q2 2024 and has held it in 3 quarters since.
  • 138 funds tracked by Wall St. Rank held Candel Therapeutics as of Q2 2026.

Based on Virtu Financial's 13F filing for Q2 2026, filed 13 Aug 2026.